ISRCTN ISRCTN22513446
DOI https://doi.org/10.1186/ISRCTN22513446
Submission date
04/09/2025
Registration date
05/09/2025
Last edited
05/09/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Flexible cystoscopy is a routine outpatient procedure used to examine the bladder. Although it is generally safe, many patients feel anxious and experience discomfort during the procedure. This study is testing whether two simple, non-invasive methods, showing patients a short educational video before the procedure and using virtual reality (VR) distraction during the procedure, can make the experience less stressful and less painful.

Who can participate?
Adult patients who need flexible cystoscopy at Ümraniye Training and Research Hospital

What does the study involve?
Patients will be randomly assigned to one of four groups: (1) video only, (2) video + VR, (3) VR only, and (4) routine care without video or VR. The video explains the procedure in simple terms, while the VR headset shows calming 360° nature scenes.

The study will measure patients' long-term tendency to experience anxiety and their current state of anxiety using questionnaires before and immediately after the procedure. Pain intensity will be assessed during cystoscopy using a scale. All procedures will be performed by experienced urologists under local anaesthesia, and data will be collected by a second physician.

What are the possible benefits and risks of participating?
The results of this study will help determine whether video education and VR distraction are effective in reducing anxiety and pain during flexible cystoscopy, and may guide improvements in patient care.

No risks given at registration.

Where is the study run from?
Ümraniye Training and Research Hospital, Department of Urology.

When is the study starting and how long is it expected to run for?
October 2024 to January 2025

Who is funding the study?
Ümraniye Training and Research Hospital, Department of Urology. (no external funding)

Who is the main contact?
Dr Murat Beyatlı, muratbeyatli_90@hotmail.com

Contact information

Dr Murat Beyatlı
Public, Scientific, Principal Investigator

Elmalıkent Mahallesi Adem Yavuz Cad. No:1 Ümraniye / İstanbul
İstanbul
34764
Türkiye

ORCiD logoORCID ID 0000-0003-0945-0051
Phone +905556405515
Email muratbeyatli_90@hotmail.com

Study information

Study designInterventional randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life, Efficacy
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleEffects of pre-procedural video education and intra-procedural virtual reality on anxiety and pain during flexible cystoscopy: a randomized controlled trial
Study acronymVR-CYSTO
Study objectivesTo evaluate whether pre-procedural video education and intra-procedural virtual reality distraction reduce anxiety and pain compared to standard care in patients undergoing flexible cystoscopy.
Ethics approval(s)

Approved 07/11/2024, Ümraniye Training and Research Hospital Ethics Committee (Elmalıkent Neighborhood Adem Yavuz Street No:1, Ümraniye/Istanbul, 34760, Türkiye; +90 (0216) 632 18 18/11 64; not@available.com), ref: 370

Health condition(s) or problem(s) studiedProcedural anxiety and pain in patients undergoing flexible cystoscopy
InterventionRandomisation is 1:1:1:1 using computer-generated allocation.
Participants are randomised into four parallel arms:
1. Pre-procedural educational video + VR headset during cystoscopy;
2. Educational video only;
3. VR headset only;
4. Control group receiving standard care (no video, no VR).
The video lasts ~3 minutes and explains the cystoscopy procedure. The VR headset shows neutral, relaxing content during the procedure until completion (average 5–10 minutes).
Intervention typeBehavioural
Primary outcome measure1. Pain intensity measured using the Visual Analogue Scale (VAS, 0–10) during the cystoscopy procedure
2. State anxiety measured using the State-Trait Anxiety Inventory – State (STAI-S) at baseline (before cystoscopy) and immediately after the procedure
Secondary outcome measures1. Trait anxiety measured using the State-Trait Anxiety Inventory – Trait (STAI-T) at baseline only, before the procedure.
2. Adverse events, defined as any complications or side effects observed during or after cystoscopy (e.g., dizziness, nausea, vasovagal symptoms), measured using medical records at one timepoint
Overall study start date07/10/2024
Completion date30/01/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants240
Total final enrolment240
Key inclusion criteria1. Age ≥18 years
2. Indication for flexible cystoscopy
3. Adequate cognitive function
Key exclusion criteria1. Current use of anxiolytics, antidepressants, or opioids
2. Prior history of cystoscopy
3. Significant cognitive or psychiatric disorders
4. Severe hearing/visual impairment preventing video or VR use
5. Active urinary tract infection or chronic bladder pain
6. History of severe allergic reaction to local anesthetics
7. Pregnancy
Date of first enrolment08/11/2024
Date of final enrolment30/01/2025

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Ümraniye Training and Research Hospital, Department of Urology
Elmalıkent Mahallesi Adem Yavuz Cad. No:1 Ümraniye / İstanbul
Istanbul
34764
Türkiye

Sponsor information

Funders

Funder type

Hospital/treatment centre

Ümraniye Training and Research Hospital

No information available

Results and Publications

Intention to publish date20/09/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe findings of this trial will be submitted for publication in a peer-reviewed scientific journal within one year of study completion and may also be presented at national and international urology conferences
IPD sharing planDe-identified or anonymised datasets of individual participant data (IPD) will be made available from the corresponding author (Murat Beyatlı, muratbeyatli_90@hotmail.com) on reasonable request after publication of the study results. Data will be shared for academic purposes only, in anonymised form, without any information that could identify individual participants.

Editorial Notes

05/09/2025: Study's existence confirmed by the Ümraniye Training and Research Hospital Ethics Committee.